ATC code A02

ATC code A02 Drugs for acid related disorders is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.^[1]^[2]^[3] Subgroup A02 is part of the anatomical group A Alimentary tract and metabolism.^[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QA02.^[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

A02A Antacids

A02AA Magnesium compounds

A02AA01 Magnesium carbonate

A02AA02 Magnesium oxide

A02AA03 Magnesium peroxide

A02AA04 Magnesium hydroxide

A02AA05 Magnesium silicate

A02AA10 Combinations

A02AB Aluminium compounds

A02AB01 Aluminium hydroxide

A02AB02 Algeldrate

A02AB03 Aluminium phosphate

A02AB04 Dihydroxialumini sodium carbonate

A02AB05 Aluminium acetoacetate

A02AB06 Aloglutamol

A02AB07 Aluminium glycinate

A02AB10 Combinations

A02AC Calcium compounds

A02AC01 Calcium carbonate

A02AC02 Calcium silicate

A02AC10 Combinations

A02AD Combinations and complexes of aluminium, calcium and magnesium compounds

A02AD01 Ordinary salt combinations

A02AD02 Magaldrate

A02AD03 Almagate

A02AD04 Hydrotalcite

A02AD05 Almasilate

A02AF Antacids with antiflatulents

A02AF01 Magaldrate and antiflatulents

A02AF02 Ordinary salt combinations and antiflatulents

A02AG Antacids with antispasmodics

A02AH Antacids with sodium bicarbonate

A02AX Antacids, other combinations

A02B Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)

A02BA H2-receptor antagonists

A02BA01 Cimetidine

A02BA02 Ranitidine

A02BA03 Famotidine

A02BA04 Nizatidine

A02BA05 Niperotidine

A02BA06 Roxatidine

A02BA07 Ranitidine bismuth citrate

A02BA08 Lafutidine

A02BA51 Cimetidine, combinations

A02BA53 Famotidine, combinations

A02BB Prostaglandins

A02BB01 Misoprostol

A02BB02 Enprostil

A02BC Proton pump inhibitors

A02BC01 Omeprazole

A02BC02 Pantoprazole

A02BC03 Lansoprazole

A02BC04 Rabeprazole

A02BC05 Esomeprazole

A02BC06 Dexlansoprazole

A02BC07 Dexrabeprazole

A02BC08 Vonoprazan

A02BC09 Tegoprazan

A02BC10 Fexuprazan

A02BC11 Ilaprazole

A02BC51 Omeprazole, combinations

A02BC53 Lansoprazole, combinations

A02BC54 Rabeprazole, combinations

A02BD Combinations for eradication of Helicobacter pylori

A02BD01 Omeprazole, amoxicillin and metronidazole

A02BD02 Lansoprazole, tetracycline and metronidazole

A02BD03 Lansoprazole, amoxicillin and metronidazole

A02BD04 Pantoprazole, amoxicillin and clarithromycin

A02BD05 Omeprazole, amoxicillin and clarithromycin

A02BD06 Esomeprazole, amoxicillin and clarithromycin

A02BD07 LansoprazoleVonoprazan/amoxicillin, amoxicillin and clarithromycin

A02BD08 Bismuth subcitrate, tetracycline and metronidazole

A02BD09 Lansoprazole, clarithromycin and tinidazole

A02BD10 Lansoprazole, amoxicillin and levofloxacin

A02BD11 Pantoprazole, amoxicillin, clarithromycin and metronidazole

A02BD12 Rabeprazole, amoxicillin and clarithromycin

A02BD13 Rabeprazole, amoxicillin and metronidazole

A02BD14 Vonoprazan, amoxicillin and clarithromycin

A02BD15 Vonoprazan, amoxicillin and metronidazole

A02BD16 Omeprazole, amoxicillin and rifabutin

A02BD17 Vonoprazan and amoxicillin

A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)

A02BX01 Carbenoxolone

A02BX02 Sucralfate

A02BX03 Pirenzepine

A02BX04 Methiosulfonium chloride

A02BX05 Bismuth subcitrate

A02BX06 Proglumide

A02BX07 Gefarnate

A02BX08 Sulglicotide

A02BX09 Acetoxolone

A02BX10 Zolimidine

A02BX11 Troxipide

A02BX12 Bismuth subnitrate

A02BX13 Alginic acid

A02BX14 Rebamipide

A02BX15 Teprenone

A02BX16 Irsogladine

A02BX51 Carbenoxolone, combinations excluding psycholeptics

A02BX71 Carbenoxolone, combinations with psycholeptics

A02BX77 Gefarnate, combinations with psycholeptics

A02X Other drugs for acid related disorders

Empty group

References

^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
^ "ATC/DDD Index 2022: code A02". WHO Collaborating Centre for Drug Statistics Methodology.
^ "ATCvet Index 2022: code QA02". WHO Collaborating Centre for Drug Statistics Methodology.

[1] "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.

[2] World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.

[3] "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.

[4] "ATC/DDD Index 2022: code A02". WHO Collaborating Centre for Drug Statistics Methodology.

[5] "ATCvet Index 2022: code QA02". WHO Collaborating Centre for Drug Statistics Methodology.

[1]

[2]

[3]

[4]

[5]

v t e Drugs for acid related disorders: Antacids (A02A)
Magnesium (increases motility)	Magnesium carbonate Magnesium oxide Magnesium peroxide Magnesium hydroxide Magnesium silicate
Aluminium (decreases motility)	Aceglutamide aluminum Algeldrate Aluminium phosphate Aluminium acetoacetate Aloglutamol Aluminium glycinate Carbaldrate
Calcium	Calcium carbonate Calcium silicate
Sodium	Sodium bicarbonate
Combinations and complexes of aluminium, calcium and magnesium	Almagate Almasilate Hydrotalcite Magaldrate

v t e Drugs for peptic ulcer and GERD/GORD (A02B)
H₂ antagonists ("-tidine")	Cimetidine Famotidine Lafutidine Lavoltidine (loxtidine) Niperotidine Nizatidine Ranitidine^#‡ Roxatidine
Prostaglandins (E)/ analogues ("-prost-")	Misoprostol Enprostil
Proton-pump inhibitors ("-prazole")	Azeloprazole Dexlansoprazole Dexrabeprazole Esomeprazole Ilaprazole Lansoprazole Omeprazole^# Pantoprazole Picoprazole Rabeprazole Tenatoprazole Timoprazole
Potassium-competitive acid blockers ("-prazan")	Fexuprazan Linaprazan Revaprazan Soraprazan Tegoprazan Vonoprazan
Others	Aceglutamide aluminum Acetoxolone Alginic acid Arbaclofen placarbil Bismuth subcitrate Carbenoxolone Cetraxate Gefarnate Irsogladine Lesogaberan Pirenzepine Proglumide Rebamipide Sucralfate Sulglicotide Telenzepine Teprenone Troxipide Zinc L-carnosine Zolimidine
Combinations	Bismuth subcitrate/metronidazole/tetracycline Omeprazole/amoxicillin/rifabutin Vonoprazan/amoxicillin Vonoprazan/amoxicillin/clarithromycin
See also: Helicobacter pylori* eradication protocols*
^#WHO-EM ^‡Withdrawn from market Clinical trials: ^†Phase III ^§Never to phase III

ATC code A: Alimentary tract and metabolism
A01 Stomatological preparations A02 Drugs for acid related disorders A03 Drugs for functional gastrointestinal disorders A04 Antiemetics and antinauseants A05 Bile and liver therapy A06 Drugs for constipation A07 Antidiarrheals, intestinal anti-inflammatory/anti-infective agents A08 Antiobesity preparations, excluding diet products A09 Digestives, including enzymes A10 Drugs used in diabetes A11 Vitamins A12 Mineral supplements A13 Tonics A14 Anabolic agents for systemic use A15 Appetite stimulants A16 Other alimentary tract and metabolism products
Other ATC codes
A B C D G H QI J L M N P R S V